Filter News
Area of Research
- (-) Materials for Computing (2)
- (-) Neutron Science (6)
- Advanced Manufacturing (1)
- Biology and Environment (1)
- Clean Energy (7)
- Computational Engineering (1)
- Computer Science (2)
- Fusion and Fission (1)
- Isotopes (1)
- Materials (11)
- National Security (2)
- Quantum information Science (1)
- Supercomputing (14)
News Topics
- (-) Biomedical (2)
- (-) Computer Science (1)
- (-) Materials Science (4)
- 3-D Printing/Advanced Manufacturing (1)
- Biology (1)
- Chemical Sciences (2)
- Composites (1)
- Coronavirus (1)
- Environment (1)
- Fusion (1)
- Isotopes (1)
- Materials (1)
- Nanotechnology (1)
- National Security (1)
- Neutron Science (12)
- Physics (2)
- Polymers (2)
- Quantum Science (1)
Media Contacts
Pengfei Cao, a polymer chemist at ORNL, has been chosen to receive a 2021 Young Investigator Award from the Polymeric Materials: Science and Engineering Division of the American Chemical Society, or ACS PMSE.
ASM International recently elected three researchers from ORNL as 2021 fellows. Selected were Beth Armstrong and Govindarajan Muralidharan, both from ORNL’s Material Sciences and Technology Division, and Andrew Payzant from the Neutron Scattering Division.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.